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smarce1 mutants have a defective 
endocardium and an increased 
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factors in zebrafish
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SWI/SNF or BAF chromatin-remodeling complexes are polymorphic assemblies of homologous subunit 
families that remodel nucleosomes and facilitate tissue-specific gene regulation during development. 
BAF57/SMARCE1 is a BAF complex subunit encoded in animals by a single gene and is a component of 
all mammalian BAF complexes. In vivo, the loss of SMARCE1 would lead to the formation of deficient 
combinations of the complex which might present limited remodeling activities. To address the specific 
contribution of SMARCE1 to the function of the BAF complex, we generated CRISPR/Cas9 mutations 
of smarce1 in zebrafish. Smarce1 mutants showed visible defects at 72 hpf, including smaller eyes, 
abnormal body curvature and heart abnormalities. Gene expression analysis revealed that the mutant 
embryos displayed defects in endocardial development since early stages, which led to the formation 
of a misshapen heart tube. The severe morphological and functional cardiac problems observed at 
4 dpf were correlated with the substantially increased expression of different cardiac transcription 
factors. Additionally, we showed that Smarce1 binds to cis-regulatory regions of the gata5 gene and is 
necessary for the recruitment of the BAF complex to these regions.
The SWItch/Sucrose Non-Fermentable (SWI/SNF) complexes are ATP-dependent chromatin remodeling 
machines that are evolutionarily conserved from yeast to humans. Their enzymatic function involves remodeling 
nucleosomal DNA, thereby facilitating the binding of transcriptional factors to nucleosomal templates1.
In vertebrates, at least 28 genes encode subunits of the SWI/SNF complex. SWI/SNF complexes (often referred 
to as BAF) can form various assemblies from homologous subunits. The subunit composition and stoichiometry 
of BAF in different cells change dynamically during differentiation and distinct combinations have been associ-
ated with specific developmental processes1–5
The central catalytic activity of the BAF complex is ATP hydrolysis. This activity is achieved by the Brahma 
(BRM/SMARCA2) or Brahma-Related Gene 1 (BRG1/SMARCA4) subunits. Three other subunits (BAF155/
SMARCC1, BAF170/SMARCC2, BAF47/SMARCB1) together with BRG1 or BRM are sufficient to reconsti-
tute a core complex capable of remodeling mononucleosomes in vitro6. Additionally, other subunits help to tar-
get the complex to specific genetic loci templates1,7,8. Mammalian BAF complexes are further subdivided into 
BAF and PBAF (Polybromo-associated BAF) complexes: BAF complexes are defined by the AT Rich Interactive 
Domain 1 (ARID) containing subunits ARID1A or ARID1B, while PBAF complexes include BAF200 as the 
ARID-containing subunit. Besides, PBAF only utilizes SMARCA4 as the ATPase and incorporates BAF180/
PBRM (polybromo), BRD7 (Bromodomain containing 7) and BAF45a9.
In recent years subunits not found in yeast have been identified. SMARCE1 is an animal-specific subunit, 
which is present in all BAF and PBAF assemblies. Its main structural feature is a high-mobility-group (HMG) 
domain, which promotes binding to four-way junction DNA10. Extensive work has demonstrated a specific role 
of SMARCE1 in the recruitment of BAF complexes to endogenous nuclear receptor targets.11,12. SMARCE1 also 
interacts with a wide range of protein partners outside the BAF complex. For example, in the mouse embryo, 
SMARCE1 is responsible for the silencing of the CD4 gene during T cell differentiation13, and during the 
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repression of neuronal genes in non-neuronal cells, SMARCE1 interacts with the transcriptional co-repressor 
Co-REST and facilitates repression14. In humans, it has been shown that mutations in SMARCE1 predispose 
to meningioma disease15,16 and to the Coffin-Siris syndrome17, and thus, this gene has been connected to 
malignancy.
The BAF complex has been widely studied in the context of mammalian heart development. In mice, muta-
tions in different subunits lead to defects in heart development and cause embryonic death. Among the mutated 
genes that produced cardiac anomalies in vivo were SMARCA418, BAF60c/SMARCD319–21, PBRM22,23. SMARCA4 
function has also been examined in zebrafish embryos. Studies in both organisms revealed that the relative levels 
of cardiac transcription factors and BAF complexes are important for proper cardiogenic expression18. On the 
other hand, SMARCD3 is a cardiac-enriched subunit of the BAF complex that assembles in a mutually exclusive 
manner into BAF to become part of what has been considered a cardio-specific cBAF complex24. The cBAF com-
plex promotes cardiomyogenic differentiation activity in mouse and zebrafish25. Previous work attempting to 
assess the relative importance of BAF and PBAF complexes in heart development, indicated that both complexes 
are functional during this process, suggesting that different assemblies of the SWI/SNF complex with distinct 
spatial or temporal remodeling activities may co-exist in the developing heart.22,26.
This study focuses on Smarce1 function in zebrafish development. SMARCE1 is a constitutive component 
of all BAF animal complexes, but it is not a core subunit. It is known that complexes with mutations in the 
HMG domain of SMARCE1 can still bind DNA and mediate ATP-dependent nucleosome disruption10, how-
ever the SMARCE1 HMG domain likely provides additional specificity during target recognition by the BAF 
complex. Therefore, the loss of this subunit would be expected to disable important functions of the BAF com-
plex. SMARCE1 inactivation is not redundant with SMARCA4 loss of function, since in SMARCE1 mutants the 
ATPase activity of the BAF complex would be intact. The understanding of the specific functions of SMARCE1 
is important because it has been noted that it exhibits relevant interactions with complexes involved in gene 
repression13,14,27,28, which leads to the question of whether the loss of SMARCE1 has different effects on particular 
properties of the BAF complex, for example repression versus activation. Zebrafish are a good vertebrate model 
to ask these questions because due to maternal inheritance, fish might survive longer with a decreased chromatin 
remodeling activity. To analyze the function of Smarce1 we generated CRISPR/Cas9-mediated mutations in the 
zebrafish gene. We found that the loss of Smarce1 produced a strong phenotype. At 72 hours of development, 
smarce1 mutants presented smaller eyes, body curvature defects and pericardial edema. We showed that mutant 
embryos have heart defects including dysmorphic chambers, absence of looping, slower beating and absence 
of circulation. These defects were accompanied with an abnormal morphology of the endocardium, which was 
detected from 20-somite stage and an augmented cardiac gene expression detected from 48 hpf. ChIP analysis 
demonstrated that Smarce1 directly binds to cis-regulatory regions of gata5, a gene that is highly upregulated in 
the mutant.
Results
CRISPR/Cas9 mutant alleles of smarce1 have strong morphological defects at 72 hpf. A search 
in the zebrafish GenBank database indicated the presence of one single gene (Gene ID: 322248) in chromo-
some 3 with homology to the mammalian SMARCE1 gene. Smarce1 protein shares a sequence identity of 77% 
and a sequence similarity of 84% to both human and mouse SMARCE1. RT-PCR analysis was performed to 
verify the expression of the gene along embryonic development. As predicted, smarce1 transcripts were clearly 
detected in all embryonic stages tested from 1-cell stage to 5dpf as well as in all organs examined at adult stages 
(Fig. S1). In addition, whole mount in situ hybridization (ISH) revealed that smarce1 transcripts were ubiqui-
tously distributed in embryos of different developmental stages (Fig. S2). To introduce CRISPR/Cas9-mediated 
mutations in the smarce1 gene we designed a guide RNA (gRNA) targeted to exon 4 of the reported genomic 
sequence. Co-injection of the gRNA with the Cas9 mRNA in single-cell embryos caused frameshift mutations 
in the smarce1 gene that created a premature stop codon leading to the production of a short, truncated peptide 
(53 aa) which lacks all the relevant domains described for Smarce1 protein, such as the HMG domain and a kine-
sin-like coiled-coiled region that is important for protein-protein interactions (Fig. 1A). Two mutant alleles with 
four- and eight-nucleotide deletions were identified among F1 fish from which lines were derived and expanded 
(Fig. 1A). Backcrosses of these alleles yielded offspring, 25% of which had morphological defects. Genotyping of 
defective embryos confirmed their smarce1−/− identity. The most conspicuous morphological defects were detect-
able at day 3 (dpf) but were fully penetrant at 4 dpf. Alterations included a slight curvature of the tail, noticeable 
smaller eyes and swelling of the pericardium (Fig. 1B). Larvae were inactive and exhibited a weak response to 
touch. By 6 dpf cardiac edema became huge and embryos could not move and die. The phenotype was the same 
for both alleles as well as for heteroallelic combinations. Thus, due to easier genotyping of the 8-base pair deletion, 
we continued the work with this allele. We confirmed the loss of Smarce1 protein by western blot analysis, where 
the protein was not detected in the homozygous embryos (Fig. S2), and by ISH, we detected the degradation of the 
smarce1 transcripts in the mutant embryos due to non-sense-mediated mRNA decay (Fig. S2). To further demon-
strate the specificity of the phenotype, we injected single-cell embryos obtained from smarce1+/− incrosses with 
synthetic smarce1 mRNA. After 4dpf we quantified the persistence of cardiac edema in the injected embryos and 
found a significant rescue of this defect in the mRNA-injected compared to buffer-injected embryos (Fig. 1C). By 
6 dpf mRNA-injected embryos showed a decrease in mortality from 25% in the buffer-injected embryos, likely 
corresponding to the homozygous individuals, to 8% in the mRNA-injected embryos (Fig. 1C). These results 
confirmed that the phenotypes observed were a direct consequence of the loss of the Smarce1 subunit.
Smarce1 is essential for heart development. The defects exhibited by the Smarce1 mutants are in gen-
eral reminiscent of those observed in the two reported smarca4 mutant alleles, young and brg1s48118,29. Because of 
the importance of chromatin remodeling during heart development, and to contribute to the identification of the 
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functional complexes that are active in the embryonic heart, we focused on this phenotypic aspect. Morphological 
analysis of the heart at 4 dpf indicated the presence of both atrial and ventricular chambers, but with a dys-
morphic aspect with the typical tube-like shape described for other zebrafish mutants with heart phenotype 
like the heartstrings mutant in the tbx5 gene30 (Fig. 2A; Movie S1). Myocardial and endocardial cell layers were 
detected in sagittal sections of mutant hearts, but the formation of the atrio-ventricular canal (AVC) was not 
evident (Fig. 2B,C). Additionally, in mutant hearts, a cavity inside the lumen could not be appreciated when 
compared to a section of a control heart (Fig. 2B,C). Images of three-dimensional reconstructions of fixed 3dpf 
mutant embryos carrying Tg(cmlc2:egfp) demonstrated the presence of differentiated cardiomyocytes, but they 
also revealed tissue disorganization and extreme cell compaction in both chambers, with atria presenting a 
higher defective aspect (Fig. 2D–F). Video imaging of live embryos indicated that the heart beating is signifi-
cantly slower (with occasional arrests) and circulation was absent (∼70%) or extremely slow (∼30%) in mutant 
embryos (Movies S1 and S2).
We performed gene expression analysis of specific marker genes at 48 hpf. ISH with the cardiomyocyte marker 
cmlc2 evidenced the failure of the looping process (Fig. 3A,B). In order to evaluate the capacity of Smarce1 to 
rescue the looping defect, we repeated the assay previously described. Embryos obtained from smarce1+/− crosses 
were injected with the smarce1 mRNA and probed with cmlc2 at 72 hpf to reveal the heart aspect. After geno-
typing, embryos were classified according to their heart morphology (Fig. 3C–H). Hearts from smarce1+/+ and 
smarce1+/− embryos injected with buffer presented a regular shape in which ventricle and atria were located side 
by side (Fig. 3C). In contrast, in hearts of smarce1−/− embryos, the ventricle was located above the atria (Fig. 3D). 
In the group of embryos injected with the smarce1 mRNA, we found that out of 15 smarce1−/− embryos, 11 
(73%) presented a normal looking heart with side by side chamber organization (Fig. 3F); two (13%) were par-
tially rescued (Fig. 3G); and two (13%) presented a very poor rescued phenotype (Fig. 3H). This result indicated 
that Smarce1 is indeed capable of restoring the heart shape. Embryos were also probed with vmhc and amhc to 
Figure 1. (A) Schematic diagram of smarce1 gene. The DNA-binding high mobility group is shown. CRISPR/
Cas9 mediated-deletions were produced in exon IV. The nucleotide sequence of the RNA-guide targeted region 
is shown in gray with the PAM in red and the deletions are indicated in lines below. (B) The body curvature, 
smaller eyes and cardiac edema are shown. (C) Graphs showing rescue experiments with injected smarce1 
mRNA. A significant lower number of edematous embryos (left) and a higher survival rate (right) were 
determined in groups of the mRNA-injected relative to buffer-injected embryos. Values represent the average of 
three independent injections of 100 ± 10 embryos per experiment. ***P < 0.001.
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evaluate the differentiation of ventricular and atrial cells respectively (Fig. 4). Both markers were detected in the 
expected domains, indicating the proper establishment of the cardiac pattern. For a more detailed evaluation 
of cardiac chamber identity we obtained chamber-specific expression patterns of the Vmhc and Amhc proteins 
through MF20/S46 immunofluorescence at 72 hpf. We found that the identity of the chambers was not altered; no 
ventricular to atrial transdifferentiation was detected, and although the morphology of both atria and ventricle 
was generally defective, the relative proportionality between chambers did not seem to be affected.
Patterning of the anterior lateral plate mesoderm is normal in the smarce1 mutants. To eval-
uate if the differentiation of the mesoderm and the endoderm in general were affected and to identify the devel-
opmental stages where cardiac defects originate in the smarce1 mutants, we determined the expression patterns 
of mesodermal, endodermal and cardiac markers during epiboly and gastrulation and in the anterior lateral plate 
mesoderm (ALPM), where the cardiac primordia is contained (Fig. S3). Expression of no tail (ntl) in mutant 
embryos at epiboly and somite stages presented a normal pattern, indicating that mesoderm development is not 
defective. Similarly, normal expression of gata5 at 50% epiboly in the germ ring and at 90% epiboly in endodermal 
cells revealed a proper formation of the endoderm. Next, we examined the expression of the early cardiac markers 
gata5, nkx2.5 and hand2, which at 6–9 somite stage are expressed in different regions of the ALPM. The expres-
sion patterns of these three genes in smarce1 mutants and wild type siblings were indistinguishable, suggesting 
that cardiac progenitor cells residing in the lateral and medial ALPM are distributed normally. At 14-somite stage 
cmlc2 expression in the mutants demonstrated a normal migration of myocardial cells. Altogether these results 
show that up to this stage, smarce1 mutants seem to have a normal heart development.
Endocardial development in the smarce1 mutants is abnormal. Markers associated to endocardial 
progenitors and vascular cells were also tested. The expression pattern of flk1 in the ALPM of 9- and 14-somite 
stage mutants did not show significant defects when compared to that of their siblings, suggesting a proper spec-
ification of endocardial progenitors (Fig. 5A–D). At 18-somite stage endocardial progenitors migrating from 
the rostral ALPM arrive to the midline, where they fuse in the region from which the heart cone will arise; by 
20-somite stage an aggregate of endocardial cells with a u-shaped morphology is formed31. Expression of flk1 
became apparent in this apex in control embryos. In contrast, in smarce1 mutants flk1 expression revealed a dis-
organized pattern suggesting an abnormal morphogenesis of the endocardium (Fig. 5E,F). nfatc1 is a molecular 
marker that is expressed in endocardial, but not vascular endothelial cells. Its earliest expression is apparent by 22 
hpf. Expression of the nfatc1 gene in embryos at 26, 30 and 35 hpf (Fig. 5G–N) confirmed the defective morphol-
ogy of the endocardium in the smarce1 mutants. Similarly, expression of gata5, which at 24 hpf becomes predomi-
nantly endocardial32, presented an abnormal pattern in the cardiac region of the mutants (Fig. 5O–Q). Altogether 
Figure 2. Morphological defects in smarce1 mutants. (A) The heart morphological defects of mutated 
embryo can be appreciated in comparison with a heart from a normal sibling (arrow) at 72 hpf. B-C. Sagittal 
sections stained with hematoxylin-eosin from 96 hpf normal (B) and mutant (C) embryos. (D–F) Confocal 
Z-projections of cmlc2:GFP/smarce1 normal (D) and defective hearts (E,F) at 72 hpf. In F nuclei were stained 
with DAPI. A: atria, AVC: atrio-ventricular canal, EC: endocardium, Ht: heart, V: ventricle. Scale bars: 25 μm.
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the analysis of these markers led to the conclusion that Smarce1 is required for the correct development of the 
endocardium in zebrafish embryos. Gene expression analysis at 24 hpf with the cmlc2 marker indicated that the 
majority of embryos identified as smarce1−/− showed a normal myocardial pattern of expression, reflecting a 
correct heart tube assembly (Fig. 5T,U). However, one out of six of the mutant embryos, displayed an abnormal 
pattern (Fig. 5V), consisting in a delayed or incomplete extension of the heart tube and a widening of the signal, 
which revealed that a dysmorphic heart starts to be detected during assembly and elongation of the heart tube. 
Given that myocardial-endocardial interactions are central to the process of heart tube assembly33, it is possible 
that the defective endocardium of the smarce1−/− mutants fails to organize the cardiomyocytes into an appro-
priate configuration for a correct shape of the heart tube. This problem could constitute one of the initial causes 
of heart misshaping in the mutants. We then analyzed the effects of the smarce1 mutation in the development of 
the atrioventricular canal (AVC). To this aim we examined nppa and versican expression at the AV boundary. In 
wild type embryos nppa expression was excluded from the AV boundary while in the mutant hearts, nppa mRNA 
was detected in the entire heart, with no clear exclusion from the AV boundary (Fig. 5R,S). A dramatic change 
in gene expression was detected for versican which marks the AV boundary in normal hearts. At 72 hpf, mutant 
embryos presented a broad expression of versican in both chambers, with the highest intensity in the lower part 
of the atrium (Fig. 5W,X). These results show that a normal AV boundary is not formed in the smarce1 mutants.
Loss of Smarce1 leads to upregulation of cardiac transcription factors. We then quantified the 
expression of cardiac transcription factors. For this purpose, we used 24, 48 and 96 hpf embryos for qPCR. 
Among the genes quantified at 24 hpf we included gata5, nkx2.5, ntl and the smarcd3 genes a and b. The Smarcd3 
subunit was considered because, as already mentioned, it has been identified as the most relevant BAF subunit 
in a cardio-specific BAF complex and together with Tbx5 and Gata5 is involved in the early induction of cardio-
myocytes. We found that none of these genes presented a change in the transcription levels at 24 hpf (Fig. S4). At 
48 and 96 hpf we quantified gata5, nkx2.5, nkx2.7, nppa, tbx5, and bmp4. At 48 hpf nkx2.5 expression increased 
five times, while its homologue nkx2.7 showed a 50% reduction, additionally gata5 presented a significant 40% 
increase of expression (Fig. 6A). At 4 dpf, all cardiac factors including nkx2.7 and with the exception of bmp4 
(not shown), presented a substantial upregulation (Fig. 6A). The TFs that showed the highest increase were gata5, 
nkx2.5 and nppa, which were elevated between 10 and 20 times. The heart-specific increase of these three factors 
was validated by ISH at 5 dpf (Fig. S4). For gata5 additional regions surrounding the yolk showed an increased 
expression. In order to estimate the upregulation levels specific to the heart of the smarce1 mutants, we quantified 
Figure 3. Rescue of the heart looping by smarce1 mRNA injection in smarce1 mutant embryos. Whole-mount 
in situ hybridization detects transcripts for the cardiomyocyte marker cmlc2. A-B. Embryos at 48 hpf showing a 
normal heart (A) and a smarce1−/− heart with a defective looping (B). (C–H) Analysis of heart looping at 72 hpf. 
Buffer injected embryos present a normal heart in control siblings (C) and a non-looped heart in all the mutants 
(D). (E–H) smarce1 mRNA injected embryos showing the rescue of the heart looping in the mutant embryos. 
Complete rescue is shown in (F); a partial rescue in (G); and the failing of rescue in (H). Scale bars: 50 μm.
www.nature.com/scientificreports/
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gata5 in hearts dissected from 4 dpf embryos. We found that gata5 expression increased six-times compared 
to control hearts (Fig. S4). Accordingly, gene expression analysis in 4 dpf embryos confirmed the presence of 
smarce1 transcripts in the heart, while in mutant embryos no expression was detected. This result showed that 
upregulation of gata5 occurs in the heart as well as in other regions of the embryo, suggesting a general participa-
tion of Smarce1 in the negative regulation of gata5.
In zebrafish nkx2.5 and gata5 are among the earliest cardiogenic markers of heart development34,35. Nkx2–5 
is activated by GATA transcription factors in vertebrates35,36. Similarly, Nkx2–5 and GATA factors cooperate to 
activate transcription of downstream genes such as nppa37,38. Due to these genetic interactions, the increased 
transcription levels of these genes in the mutant could be due to the dysregulation of either of them. For this rea-
son, we aimed to analyze the possibility of a direct interaction between Smarce1 and the gene targets identified. 
To this purpose, we performed chromatin immunoprecipitation using the SMARCE1/BAF57 antibody. Since 
regulatory regions of the nkx2 and the nppa genes have not yet been reported, we focused on gata5. Previously, 
three functional cis-regulatory regions and a basal promoter sequence were identified for the gata5 gene39. Two of 
these modules (C and B) respectively located approximately 17 and 8 kb upstream of the transcription initiation 
site (TIS), as well as the promoter sequence, were shown to bind in vivo to the Otx2 transcription factor during 
transcriptional activation. In contrast, the evolutionarily conserved module A located between 1.8 and 1.4 kb 
upstream of the TIS did not bind to Otx2. Based on these genomic regions we performed chromatin immuno-
precipitation using 72 hpf wild type embryos and the SMARCE1 antibody. Of interest, we found that module A 
and B and the promoter were clearly enriched in this experiment, while module C was not amplified (Figs 6B and 
S5). The enrichment of these modules was not observed when smarce1 mutant embryos were tested. Moreover, 
when antibodies for other BAF subunits including the core subunit Smarca4 and the alternative subunits Arid1a 
and Pbrm were used, amplification of the same modules was observed in the wild type embryos, whilst no sig-
nal was produced from smarce1 mutant embryos (Fig. S6). This result indicates that Smarce1 is essential for the 
recruitment of the BAF complex to the gata5 regulatory regions, and it shows that both the BAF and the PBAF 
complexes bind to these regions.
In conclusion, our results indicate that Smarce1 activity correlates with the downregulation of gata5 cardiac 
transcription factor in 2–4 dpf embryos. Smarce1 binds to gata5 and recruits the BAF remodeling complex, but 
further experiments are needed to support a direct function of Smarce1 and the BAF complex in the repression 
of gata5. It also remains to be determined whether Smarce1 binds the other target genes identified, or if the 
increased transcription levels of these genes in the mutant, reflect the dysregulation of gata5.
Figure 4. Patterns of expression of atria and ventricle markers in smarce1 mutants. Chamber expression in 
smarce1 heterozygous (upper panel) and homozygous (lower panel) embryos. Left to right: 48 hpf embryos 
showing the expression of the ventricular cardiomyocyte marker vmhc, embryos showing the expression of the 
atria cardiomyocyte marker amhc, 72 hpf embryos stained with MF20 and S46 antibodies to detect the ventricle 
(red) and atrium (green) in wildtype and mutant embryos. Scale bar: 25 μm.
www.nature.com/scientificreports/
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Discussion
In this work, we studied the function of the Smarce1 subunit in the development of the zebrafish embryo. To this 
aim we introduced CRISPR/Cas9 mutations in the smarce1 gene. SMARCE1 is a constitutive subunit of both of 
the SWI/SNF complexes BAF and PBAF, and therefore, very early and dramatic defects could have been expected 
in the loss of function. Nonetheless we found that two different alleles of smarce1 mutants seemed normal until 3 
dpf, likely due to a maternal rescue and probably because some combinations of the BAF complex might remain 
functional. Detectable morphogenetic defects in the smarce1 mutants at 4 dpf included smaller eyes, body curva-
ture defects and pericardial edema. The heart defects were analyzed in more detail. These defects were severe in 
Figure 5. Defects in the endocardium in smarce1 mutants. Embryos at 9- (A,B), 14- (C,D) and 20- (E,F) 
somite stage showing the expression the endothelial marker flk1. While a normal ALPM pattern is observed 
in mutant embryos up to 14 somites, at 20 somite stage mutant embryos present an abnormal distribution of 
endocardial cells. Expression of nfatc1 in embryos at 26 (G-I), 30 (J–L) and 35 hpf (M,N) reveals a disorganized 
pattern of the endocardium. Embryos at 24 hpf showing expression of the endocardial marker gata5 (O–Q) 
and the myocardial marker cmlc2 (T–V). Expression of gata5 in the endocardium of the mutant embryos is 
abnormal and has a lower signal. A dysmorphic pattern for cmlc2 is detected in one out of six embryos (V). R,S. 
Expression of nppa in 48 hpf embryos. An arrow shows the absence of nppa at the atrioventricular junction.  
(W, X) Expression of versican in embryos at 4 dpf. Scale bars: 50 μm.
www.nature.com/scientificreports/
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the mutant: circulation was impaired, and heart contractions were arrhythmic, slower and with sporadic arrests. 
Gene expression analysis at early development demonstrated that cell lineage determination and ALPM pattern-
ing were normal in the smarce1 mutants. Similarly, we demonstrated that atrial and ventricular cardiomyocytes 
were differentiated and chamber domains were properly determined. However, from 20-somite stage onwards, we 
detected a disorganized pattern of endocardial cells in the mutant embryos. Additional experiments are needed 
to determine the origin of the abnormal endocardial development, which could be the result of a deficient differ-
entiation of the endocardial progenitors or a deficient migration towards the cardiac field, among other causes. 
Previous work has shown the importance of the endocardium for the organization of cardiomyocyte movement 
during heart tube assembly. Thus, it is likely that the primary defect of the smarce1 mutants is associated with 
a deficient regulation by the endocardium of cardiomyocyte movement. This limitation might determine the 
absence of heart looping that is detected later in the homozygous embryos. The endocardium also is an impor-
tant component of the AVC40. We found evidence indicating that expression at the AV boundary is not correctly 
restricted in the mutant hearts and in histological sections of the smarce1 mutants we were unable to detect valve 
tissue. Therefore, it is possible that endocardial defects also affect the development of the AVC. A more detailed 
analysis of AVC markers is needed to establish the AVC morphology in the smarce1 mutants.
We found that in the absence of Smarce1 a number of cardiac transcription factors are over-expressed. For 
gata5 we demonstrated that there is a direct interaction between Smarce1 and different gata5 regulatory regions. 
Figure 6. (A) Quantitation by QPCR of gene expression of cardiac factors. 2 dpf and 4dpf embryos were 
genotyped and evaluated. For all genes n ≥ 3. *P < 0.05, **P < 0.01. (B) In vivo Smarce1-binding sites were 
detected by chromatin immunoprecipitation using a SMARCE1 antibody. Cropped gel images representing 
typical results from ChIP assays in: the regulatory module located from the transcription initiation site +1 to 
−1415, which includes the basic promoter (gata5-Bp), the module located from −1469 to −1892 (gata5-A), the 
module located from −7823 to −8213 (gata5-B) and the module located from −16805 to −17147 (gata5-C). 
IgG, Smarce1, Smarca4, Arid1a and Pbrm indicate the PCR products from genomic DNA precipitated using the 
corresponding antibody. WT and Mut indicate the source of genomic DNA. The input is the PCR product from 
the total input genomic DNA. Full-length gels are presented in Supplementary Figure 3.
www.nature.com/scientificreports/
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This finding indicates that Smarce1 could be involved in the repression of this gene which occurs after 48 hpf, sug-
gesting that down-regulation of some cTFs is required for further aspects of development after their participation 
in chamber formation. Significantly, we showed that other BAF subunits also bind to the same gata5 regulatory 
regions and that their binding is dependent on the presence of Smarce1. This result highlights the importance of 
Smarce1 as a mediator of the interaction between the gata5 gene and the BAF complex. A relevant observation 
is that none of the genes quantified presented transcriptional changes at 24 hpf. This finding indicates that the 
first cardiac phenotype observed during the formation of the linear heart tube precedes the changes of expression 
identified here. It is likely that other genes important for the differentiation and migration of endocardial cells are 
dysregulated at earlier stages in the ALPM. In this regard, it would be interesting to quantify the expression of the 
transcription factor Scl/Tal1 or of genes associated with the Slit/Robo signaling pathway.
Other examples of repression of cardiac gene transcription by BAF subunits have been previously reported 
in mice. For instance, in cultured P19 cells during differentiation of cardiomyocytes, ARID1a has been shown to 
directly repress cardiac gene transcription through physical interactions with the NURD complex41. Additionally, 
in the sinoatrial node of mouse adult hearts ARID1a cooperates with Tbx3 and histone diacetylase 3 to repress 
the expression of Nkx2–542. It is clear that different combinations of the BAF complex with alternative remodeling 
activities co-exist in the developing heart. At early stages, mouse SMARCD3 interacts with GATA4 and TBX5 
transcription factors, and the three of them together cause the recruitment of the BAF complex to occupy and 
open cardiogenic loci in chromatin such as the early enhancer of Nkx2–5. It is possible that other BAF combina-
tions promote the closing of chromatin at later stages. Although Smarce1 is present in all putative combinations, 
we speculate that it is an important subunit in the complex when repressive activities are required. Significantly, 
Smarce1 itself has been shown to participate as a repressor in different contexts. One of the best described is 
the repression of CD4 in mouse T cells, where SMARCE1 participates in the remodeling of chromatin at the 
CD4 silencer thereby enabling the repressor Runx1 to access the silencer and repress CD413,43. In human cells 
SMARCE1 and SMARCA4 associate with the methyl-CpG-binding protein MeCP2, and they assemble together 
in the chromatin of methylated genes and cooperate to silence genes such as the fragile X syndrome FMR1 gene27. 
Interactions of SMARCE1 with repressor complexes such as co-REST in non-neuronal cells have also been 
reported.
In conclusion, in this work we found that the loss of Smarce1 does not affect the initial steps of develop-
ment. At later stages, Smarce1 is critical for endocardial development, heart tube formation and heart looping 
and posteriorly, it functions to repress cardiac gene transcription. This finding is relevant to human genetics as 
Smarce1 gene in humans has been associated with the Coffin-Siris syndrome, a disease that includes congenital 
heart problems. Clearly, other essential roles for Smarce1 are inferred in addition to the one described in cardiac 
development.
Methods
Fish maintenance and strains. A zebrafish (Danio rerio) AB-TU-WIK hybrid line was used. The embryos 
were obtained by natural crosses and raised at 28 °C based on standard procedures44. Staging was performed 
according to the Kimmel system45. Zebrafish were handled in compliance with local animal welfare regulations 
and all experimental protocols were approved by the Comité de ética (Instituto de Biotecnología, UNAM).
CRISPR/Cas9-mediated mutations and genotyping. CRISPR/Cas9 target sites were designed using 
an online tool ZiFiT Targeter software (http://zifit.partners.org/ZiFiT). The smarce1 genomic target sequence is 
5′CCTACAACAACTACAGGCTGG3′, located at exon 4. The primers 5′AAACGCCTGTAGTTGTTGTAGG3′ 
and 5′TAGGCCTACAACAACTAGAGGC3′ were annealed and cloned into the pDR274 plasmid46 used BsaI. 
sgRNA was synthesized using T7 RNA polymerase (Roche). AmpliCap SP6 High Yield Message (CellScript) was 
used for the Cas9 mRNA synthesis using the pCS2-nls-zCas9-nls plasmid47. One-cell stage embryos were injected 
directly into the cell with ~13 ng/μl of sgRNA, and ~40 ng/μl of Cas9 mRNA diluted in 100 mM KCl. Embryos 
injected only with Cas9 were used as controls.
The targeted genomic locus was amplified with Phusion High-Fidelity DNA Polymerase (Thermo) 
from single embryos or larvae using the following primers: 5′CATCGCGTACCCACATCCAC3′ and 
5′TCCTCTCGGCTGGGCTTTTA3′, with annealing to sites ~302 and ~96 bp upstream and downstream from 
the target site respectively. The PCR product was cloned into a TOPO plasmid (Invitrogen) for sequencing. For 
genotyping, the primers 5′TCTGGCCTACAACAACTACA3′ and 5′TCCTCTCGGCTGGGCTTTTA3′ were 
used, flanking the mutated site, to amplify a 121 bp fragment, and PCR products were separated by the heterodu-
plex formation assay on 14% polyacrylamide gels, as described in48.
mRNA synthesis and rescue experiments. The pCS2+ plasmid containing the cDNA of smarce1 was 
used for mRNA synthesis with the mMessage mMachine SP6 kit (Ambion). Previous to the rescue assays 100, 
400 and 800 pg of smarce1 mRNA were separately injected into wild type embryos to generate a dosage-response 
curve. The optimal amount of mRNA that did not produce a significant number of dead or defective embryos 
in comparison to buffer-injected controls was 400 pg. For the subsequent experiments one-cell stage embryos 
obtained from heterozygous crosses were injected with 400 pg of smarce1 mRNA.
Histology. Embryo were fixed overnight at 4 °C in Bouin´s solution and then dehydrated by a series of graded 
ethanol. Samples were embedded with paraffin after xylene. Tissue sections of 10 μm were cut and stained in 
hematoxylin-eosin based on a reported protocol49. Subsequently, sections were mounted and photographed on a 
Leica DMLB microscope equipped with an AxioCam MR5 (Zeiss) camera.
In situ hybridization. The RNA in situ hybridization using DIG-labeled antisense RNA probes was per-
formed from reported standard protocols50. The plasmids used for in situ probe synthesis were previously 
www.nature.com/scientificreports/
1 0ScIeNtIFIc RePoRtS |  (2018) 8:15369  | DOI:10.1038/s41598-018-33746-8
described and generously donated as follows: nkx2.5, cmlc2/myl7, amhc and vmhc by Ian Scott25, gata5, versi-
can, nppa and hand2 by Deborah Yelon51, flk1 by Stephanie Woo31 and nfatc1 by Saulius Sumanas52. For synthe-
sis of the baf57 in situ probe the following primers were designed: 5′CACAACTCTCCAGCCTACCTT3′ and 
5′TTGTGGCTGGGTGGGCA3′.
Microscopy and analysis. For live imaging, embryos were anaesthetized using 0.016% tricaine (Sigma). 
Both live and fixed embryos were mounted in 0.6% low-melting agarose. Fluorescent image acquisition was per-
formed using a Zeiss LSM exciter on an Axio Observer confocal microscope. Confocal stacks were processed 
for maximum intensity projections with Zeiss ZEN2009 software or ImageJ software. Images were adjusted for 
brightness and contrast using ImageJ. 3D reconstructions and movies were assembled using ImageJ.
Immunofluorescence. Whole-mount immunofluorescence was performed as previously described51 using 
the monoclonal antibodies MF20 and S46 (Developmental Studies Hybridoma Bank). The secondary reagents 
goat anti-mouse IgG1–FITC (fluorescein isothiocyanate) and goat anti-mouse IgG2b–TRITC (tetramethyl-
rhodamine isothiocyanate) (SouthernBiotech) recognize S46 and MF20, respectively. MF20 or S46 positive signal 
were observed by confocal microscopy.
Real-time PCR analysis. For standard experiments, groups of approximately 20 embryos were collected and 
transferred to the Trizol Reagent (Ambion) for RNA extraction following the manufacturer’s instructions. When 
isolated hearts were used, 15 hearts were dissected with a needle as previously described53 and transferred to 
Trizol. After DNAse I (Thermo) treatment,1 μg was used for reverse transcription with M-MLV (Invitrogen) with 
oligo dT. cDNA was diluted 1:40 in 20 μl quintuplicate reactions. The Maxima SYBR Green Reagent (Thermo) was 
used for qPCR in a Light Cycler 480 (Roche), using the following program: 95 °C, 5 min; (95 °C, 15 s; 58 °C, 20 s; 
72 °C, 30 s-single quantification at this step-) ×40 cycles; and a melting curve from 72 to 95 °C holding during 
5 s each 0.5 °C was performed. A relative quantification with the Light Cycler 480 software was performed with 
at least three of the five replicates that displayed similar reaction curves, after normalizing to the expression level 
of the elongation factor 1 alpha (ef1alpha) and using a second derivative maximum method. myl7, amhc, vmhc, 
nkx2.5, tbx5 and gata5 primers were reported in54, ntl in55.
Western blot. Lysates were prepared using the Active Motif kit protocol. Proteins were quantified by 
Bradford assay (Bio-Rad) according to the manufacturer’s instructions. Proteins were separated by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE). The gels were blotted onto a Nitrocellulose 
Membrane (Bio-Rad) and blocked with 5% non-fat dry milk and reacted with the appropriate antibodies for 
BAF subunits: anti-BAF57/SMARCE1 antibody (Abcam ab131328) and anti-SNF5/SMARCB1 antibody (Abcam 
ab126734), which are rabbit monoclonal against the human subunits and are known to cross-react with zebraf-
ish Smarce1 and Smarcb1 respectively, all membranes were incubated with anti-ERK2 antibody (Santa Cruz 
Biotechnology, USA; Cat. Nr. sc-153) to confirm equal protein loading. The blots were posteriorly incubated 
with horseradish peroxide HRP-conjugated anti-mouse IgG or HRP-conjugated anti-rabbit IgG (Santa Cruz 
Biotechnology). Chemiluminescence was detected with enhanced chemiluminescence (ECL) western blot detec-
tion kits (Thermo Scientific Pierce).
Chromatin immunoprecipitation (ChIP). For immunoprecipitation, 100 zebrafish larvae at 4 dpf 
were used. Chromatin immunoprecipitation was performed as described previously56 with few modifica-
tions. First, sonication was used to shear the DNA with an ultrasonic disintegrator (model cv 334 Soniprep 
150 MSE) set at medium, with 30 s ON and 30 s OFF for a total of 6 cycles. DNA was kept on ice during the 
sonication. The sizes of the DNA fragments ranged from 300 to 500 base pairs and were validated by gel elec-
trophoresis. Immunoprecipitation (IP) was performed using 1.5 μg (15 μl × 0.1 μg/μl) of BAF57/SMARCE1, 
BRG1 (Abcam ab110641), ARID1A (NB100-55334 Novus Biological), BAF180/PBRM1 (ARP39332_P050 
Aviva Systems Biology) antibodies (or IgG) bound to 20 μl of dynabeads in 80 μl of RIPA buffer at 4 °C, and 
the beads were added to 100 μl of chromatin. The products were reverse-crosslinked, and the DNA was eluted 
with 50 μl of elution buffer and then purified by phenol:chloroform:isoamylalcohol extraction. The PCR prim-
ers gata5-chip-A gata5-chip-B gata5-chip-C used to check the chromatin immunoprecipitation results were 
reported in39, and for gata5-chip-Bp, the following primers were designed: 5′ACCTCGACGGCGATATTCAA3′ 
and 5′ATCATCCGCGGGAATCAAGC3′. Forty PCR cycles were performed to check for enrichment.
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